Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Becher

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Nature Medicine|February 1, 2002
Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamineMarcela V Karpuj, Mark W Becher, Joe E Springer, et al.
Progress in Brain Research|February 5, 1999
Pathogenesis of neurodegenerative diseases associated with expanded glutamine repeats: new answers, new questionsC A Ross, R L Margolis, M W Becher, et al.
Neurobiology of Disease|July 17, 1998
Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat lengthM W Becher, J A Kotzuk, A H Sharp, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 1997
Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutantL I Bruijn, M F Beal, M W Becher, et al.
Oncogene|March 14, 2007
Ligand-dependent activation of the hedgehog pathway in glioma progenitor cellsM Ehtesham, A Sarangi, J G Valadez, et al.
Science (New York, N.Y.)|December 21, 1984
Evidence for cholinergic neurites in senile plaquesC A Kitt, D L Price, R G Struble, et al.
The Journal of Cell Biology|November 1, 1996
Neurofilament subunit NF-H modulates axonal diameter by selectively slowing neurofilament transportJ R Marszalek, T L Williamson, M K Lee, et al.
Annals of Neurology|October 20, 1998
Does CAG repeat number predict the rate of pathological changes in Huntington's disease?A Rosenblatt, R L Margolis, M W Becher, et al.
JAMA|December 26, 2001
Oculopharyngeal muscular dystrophy in Hispanic New MexicansM W Becher, L Morrison, L E Davis, et al.
Nature|May 15, 1997
Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesodermP C Wong, H Zheng, H Chen, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Nature Medicine|February 1, 2002
Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamineMarcela V Karpuj, Mark W Becher, Joe E Springer, et al.
Progress in Brain Research|February 5, 1999
Pathogenesis of neurodegenerative diseases associated with expanded glutamine repeats: new answers, new questionsC A Ross, R L Margolis, M W Becher, et al.
Neurobiology of Disease|July 17, 1998
Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat lengthM W Becher, J A Kotzuk, A H Sharp, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 1997
Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutantL I Bruijn, M F Beal, M W Becher, et al.
Oncogene|March 14, 2007
Ligand-dependent activation of the hedgehog pathway in glioma progenitor cellsM Ehtesham, A Sarangi, J G Valadez, et al.
Science (New York, N.Y.)|December 21, 1984
Evidence for cholinergic neurites in senile plaquesC A Kitt, D L Price, R G Struble, et al.
The Journal of Cell Biology|November 1, 1996
Neurofilament subunit NF-H modulates axonal diameter by selectively slowing neurofilament transportJ R Marszalek, T L Williamson, M K Lee, et al.
Annals of Neurology|October 20, 1998
Does CAG repeat number predict the rate of pathological changes in Huntington's disease?A Rosenblatt, R L Margolis, M W Becher, et al.
JAMA|December 26, 2001
Oculopharyngeal muscular dystrophy in Hispanic New MexicansM W Becher, L Morrison, L E Davis, et al.
Nature|May 15, 1997
Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesodermP C Wong, H Zheng, H Chen, et al.
Pageof 6